What Reference Analytics GmbH does

Reference Analytics GmbH, now operating as Conscio Pharma Austria GmbH following a rebrand, is a GMP-certified pharmaceutical analytical services laboratory headquartered in Eisenstadt, Burgenland, Austria. The company was founded in 2012 and operates from a single location at Thomas-Alva-Edison Straße 1, AT-7000 Eisenstadt, employing a small team of approximately eight people. The business serves pharmaceutical manufacturers developing or producing small molecules, peptides, proteins, and complex drug formulations, with services spanning the full product lifecycle from method development and method transfer through validation to product release for market authorization.

The company's core technology stack is a GMP-certified analytical laboratory that applies physicochemical and chromatographic methods for drug substance and drug product characterization and quality control. Its service portfolio includes physicochemical analysis, chromatographic methods, Surface Plasmon Resonance (SPR) biosimilar analysis, nitrosamine testing (including NDSRI and Call for Review services), cleaning validation, residual solvent analysis per ICH guidelines, and validation/verification of analytical methods. Domain expertise in nitrosamines and biosimilar comparability is highlighted as a differentiator, alongside consulting for regulatory compliance challenges.

The business model is a direct B2B services model with bespoke, quote-based pricing and no publicly disclosed rates. Go-to-market relies on a regional Austria-focused distribution scope, a corporate website (consciogroup.at / consciopharma.at) for professional discovery, and direct outreach via phone (+43 (0)2682 222 77) and email ([email protected]). No intermediary, marketplace, paid marketing, or partnership channels are referenced. Ownership structure is undisclosed; the entity is a privately held Austrian GmbH with no parent company, institutional investors, or funding rounds mentioned in available data.

Name

Reference Analytics GmbH

Legal name

Conscio Pharma Austria GmbH

Website

https://consciopharma.at

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Reference Analytics GmbH (rebranded Conscio Pharma Austria GmbH) is a GMP-certified Austrian analytical laboratory providing physicochemical, chromatographic, nitrosamine, biosimilar (SPR), and validation services for pharmaceutical manufacturers developing small molecules, peptides, and proteins.

Ownership category

akta.pro rank

Product category

Pharmaceutical Analytical Services

NAICS

Scientific Research and Development Services (5417), Testing Laboratories and Services (54138)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Small-Molecule Analytical Development & Method Validation (CMC) (HLAGAHAF)

akta.pro secondary industries

Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG), Release Testing & Batch Certification (QC) (HLAGADAC)

Keywords

• Pharmaceutical analytical services
• GMP-certified testing
• Drug substance analysis
• Method validation services
• Nitrosamine testing

Headquarters

HQ city

Eisenstadt

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels1 record

Core offering

Reference Analytics GmbH is a GMP-certified contract analytical laboratory providing pharmaceutical testing and analytical method services for drug substance manufacturers. Its work covers physicochemical and chromatographic characterization, method development/transfer/validation/verification, nitrosamine and NDSRI impurity testing, SPR biosimilar analysis, cleaning validation, and residual solvent analysis for small molecules, peptides, and protein-based therapeutics across the full product lifecycle from development to market release.

Product overview

Reference Analytics GmbH (trading as Conscio Pharma Austria GmbH) is a GMP-certified, independent pharmaceutical analytical services company offering a comprehensive portfolio of testing and consulting services. The company provides physicochemical and chromatographic analytical methods, SPR biosimilar analysis, drug analysis, nitrosamine testing (including NDSRI characterization), method validation/verification, cleaning validation, and residual solvent analysis. Services are tailored for small molecules, peptides, proteins, and complex drug formulations throughout the entire product lifecycle from method development and transfer through validation to market release.

Differentiator

Problem solved

Functional benefit

Products and services

• Physicochemical Methods (Physikochemische Methoden) Physicochemical characterization and quantitative analysis of drug substances, including tests conducted under GMP guidance to support pharmaceutical development and quality control. Targeted at pharmaceutical manufacturers and sponsors needing regulated characterization data for small molecules, peptides, and proteins.
• Chromatographic Methods (Chromatographische Methoden) Chromatographic separation and quantification services for pharmaceutical drug substances and related impurities, executed under GMP-compliant conditions. Used by pharmaceutical companies to support identity, purity, and content testing across the product lifecycle.
• SPR Biosimilars Analysis Surface plasmon resonance (SPR) biosensor-based characterization and comparability analysis for biosimilar drug substances. Targets pharmaceutical manufacturers developing biosimilars who need binding and comparability data against reference products.
• Consulting Expert consulting on pharmaceutical analytical questions, supporting clients in planning, interpretation, and regulatory-relevant strategy for analytical programs. Aimed at pharmaceutical companies requiring experienced analytical and regulatory guidance.
• Drug Analysis (Arzneimittelanalyse) Analytical services covering the entire product lifecycle of drug substances (Arzneimittel) — from development through to market release — for small molecules, peptides, and proteins. Served to pharmaceutical manufacturers needing a single contract laboratory for ongoing GMP analytical support.
• Nitrosamine Testing Targeted impurity testing for nitrosamines and NDSRI (nitrosamine drug substance-related impurities) in drug substances and products, supporting regulatory risk assessment and mitigation requirements. Intended for pharmaceutical companies responding to EMA/FDA nitrosamine guidance.
• Method Validation and Verification (Validierung / Verifizierung) GMP-compliant method validation and verification services for pharmaceutical analytical procedures used to test drug substances. Provided to pharmaceutical manufacturers that require regulatory-grade evidence of method suitability for release and stability testing.
• Cleaning Validation (Reinigungsvalidierung) Analytical testing to support cleaning validation of pharmaceutical manufacturing equipment, including residue detection on production surfaces. Served to pharmaceutical manufacturers required to demonstrate acceptable cleaning procedures under GMP.
• Residual Solvent Analysis (Restlösemittel) Analytical determination of residual solvents in drug substances and drug products in line with ICH Q3C and pharmacopoeial requirements. Targeted at pharmaceutical manufacturers that need regulatory-grade residual solvent data for release and registration.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Celerion: Clinical and bioanalytical services firm offering method development, validation, and sample analysis for pharma sponsors; overlapping GMP analytical testing capabilities in a similar scale band.
• Anacura: Belgian GMP-certified analytical services provider for pharmaceutical companies including method development, validation, and release testing; direct European competitor with similar boutique positioning.
• Pacific BioLabs: Contract analytical and biosafety testing lab serving pharma and biotech sponsors with method validation and product release testing; closely comparable boutique GMP testing provider.
• Nelson Labs: Specialized laboratory services firm focused on pharmaceutical and medical device testing including extractables/leachables and method validation; similar-sized specialist competing for GMP analytical work.

Broad incumbents

• Intertek: Global testing and quality assurance provider with pharmaceutical services including method validation, residual solvent analysis, and release testing; comparable GMP-certified offerings across a broader portfolio.
• Eurofins Scientific: Global testing giant with extensive pharmaceutical analytical services including nitrosamine and biosimilar testing; broader portfolio and far larger scale than Conscio but overlapping in CMC analytical testing for pharma.
• SGS SA: Swiss-based multinational offering pharma testing, method validation, and release services across small molecules and biologics; competes for the same GMP analytical work as Conscio but at global scale.
• WuXi AppTec: Global CRO/CDMO with extensive analytical chemistry, biosimilar characterization, and CMC services; significantly larger scale and broader footprint than Conscio but highly comparable analytical service line.
• Charles River Laboratories: Large CRO providing bioanalytical, biosafety, and CMC services including method development and validation for pharma sponsors; a much larger incumbent competing for analytical services work.

Regional players

• Synlab Pharma Services: European diagnostics and pharma testing network offering analytical services across multiple countries; regional overlap with Conscio's Central European pharma testing market though at considerably larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/conscio-pharma-gmbh

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reference Analytics GmbH